Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Saturday, October 10, 2026

Back to today

From X

@calvinblissett 1 click

Calvin Blissett on X

$CHRD: 6.5x FCF, Good CEO, buying back lots of stock, low-cost pure play EP. 8% FCF yield at $60 WTI. No meaningful leverage CHRD trades at ~$142, market cap ~$7.74B, enterprise value ~$8.63B. Dividend yield ~3.7% ($5.20 annual base). Buyback/total shareholder yield is higher: policy returns ≥75% of adjusted free cash flow (mostly buybacks after the base dividend) at current low leverage (<0.5x). On 2026 guidance of ~$1.3B Adj. FCF, this implies a potential total cash return yield in the low-to-mid teens. Valuation is low: ~9.5x TTM P/E, ~7.6x forward P/E, EV/EBITDA ~3.2-3.6x, P/FCF ~6.5x. Analyst consensus PT ~$166-174 (~20%+ upside); highs to $193. Marcellus non-op sale (to POSCO, expected Q4 2026 close) provides ~$550M gross proceeds, sharpening pure-play Williston focus, boosting cash/flexibility for returns or balance-sheet strength, and removing a non-core asset. Reasons for future growth: Flat-to-low absolute oil volumes (maintenance program ~161 MBopd oil) but rising per-share metrics via efficiency and buybacks. Longer laterals (majority of program, including 4-mile) cut costs/breakevens and improve recovery; base production enhancements and lower declines support volumes with less capital. Pure-play focus post-sale plus disciplined consolidator role in the Bakken. Efficiency gains already drove material FCF improvements. LTM Owner’s Earnings (Buffett-style): Roughly Net Income + DD&A + other non-cash charges − maintenance CapEx (and normalized for WC/one-time items). For this E&P, nearly all CapEx is maintenance to offset natural declines, so Owner’s Earnings approximates free cash flow. TTM (to ~Jun 30, 2026): Operating cash flow ~$2.59B, CapEx ~$1.40B → FCF ~$1.19B. DD&A ~$1.54B; Net Income ~$841M. Company-reported adjusted FCF (preferred operational proxy) was strong in 1H26 (~$738M combined Q1+Q2) and has been running at an elevated rate. This is a rigorous, cash-based measure after the capital required to sustain the business. Expected next-12-months Owner’s Earnings: ~$1.3B adjusted free cash flow (company 2026 guidance, including derivatives, at $75 WTI / $3 HH for 2H). Why higher than LTM: stronger realized oil prices vs. prior periods, operational efficiencies (longer laterals, cost controls, base enhancements), volumes at/above high-end of prior guidance, and capital discipline (CapEx held ~$1.4B midpoint). The $550M Marcellus proceeds is one-time cash (not recurring earnings) that further supports returns and balance-sheet optionality. At ≥75% payout, this supports substantial shareholder distributions while maintaining a strong BS. Business simply: Pure-play Williston Basin (Bakken) E&P—largest operator there. Drills oil-focused horizontal wells, produces/sells crude, NGLs, and gas. High-quality inventory; shift to longer laterals improves economics. Management: Danny Brown (CEO; prior Oasis/Anadarko). Track record of efficiency, synergies, disciplined capital allocation, and per-share value creation. Capital allocation: Base dividend + aggressive buybacks under the 75%+ Adj. FCF framework (leverage-dependent). Share count reduced meaningfully; cumulative returns large relative to market cap. Maintenance production focus. Risks: Oil price sensitivity/volatility (primary driver), basin decline/inventory longevity, execution on laterals or M&A, regulatory factors in ND/MT, energy transition headwinds. Margin of safety & upside: Low leverage, high cash generation even at moderate oil prices ($60-70 WTI still supports solid FCF/returns), conservative CapEx, and efficiency gains provide protection. Upside from multiple expansion toward peers/history, continued buyback accretion to per-share metrics, operational outperformance, oil strength, and pure-play clarity. Consensus implies ~20%+ near-term upside; higher in stronger commodity scenarios. Attractive FCF yield + value profile in E&P. Figures based on company results/guidance, market data, and analyst notes as of early October 2026. Oil prices and execution remain key variables.
@calvinblissett

Calvin Blissett on X

$OPBK: Korean American depositor focus across Southern CA, TX, NV, WA. LTM Owner's Earnings=27.32m 7.8x multiple. 3.7% dividend. At book. 12 full service branches and 1 loan production office (LPO). SBA preferred lender status allows them to unload 75% of loans at a premium. Focused on real estate and housing. 1h 2026 closed 5 LPOS due to "limited market demand" was outside core geography. NPLS +22.7% from YE 2025 to Q2 2026. Cost of deposits end of Q2 2.93%, more than 50% are CDs which is bad as they are not sticky and rate sensitive.
@calvinblissett

Calvin Blissett on X

$FF: $195m EV, 30-40m current EBITDA est at RIN prices. 30m in hidden Arkansas land value (1.7k A out of 2.2k not being used) Thesis: Future Fuel's economics are primarily a bet on biodiesel margins. FF owns a relatively high-cost 59-million-gallon-per-year biodiesel plant, so it generally needs stronger industry margins than larger competitors to justify running at high utilization. The reason a high-cost producer like FF can still matter is the Renewable Fuel Standard (RFS): refiners must satisfy EPA-mandated renewable-fuel volumes, either by blending fuel or acquiring RIN credits. When mandated demand approaches or exceeds economical industry supply, the D4 RIN price rises until the marginal/high-cost producers have enough incentive to restart. FF is one of those marginal producers. That is the core thesis today. D4 RINs have risen sharply from roughly $0.50 in the depressed period to around $1.50, reflecting tighter expected supply/demand, while the EPA's much higher 2026–27 requirements should require substantially more biomass-based diesel production. If the industry remains short of required supply and the RIN bank is drawn down, RINs and therefore biodiesel margins should remain high enough to keep FF operating profitably; roughly speaking, every $0.10/gallon of sustainable margin on ~50 million gallons equals ~$5 million of annual operating profit. A return toward $0.30–$0.50/gallon margins could mean ~$15–25 million of biodiesel operating profit, versus very little or losses when margins collapse. The catalysts are higher plant utilization, continued tight D4 RIN supply/2027 RIN-bank depletion, and stronger chemicals earnings; the major risk is the opposite—RIN prices fall because supply increases, EPA policy weakens demand, exemptions expand, or renewable-diesel capacity overwhelms the market. In simple terms: FF is the expensive factory that the market may now need to run, and the RIN price is effectively what determines whether it gets paid enough to do so.
@calvinblissett

Calvin Blissett on X

$OC: Trading at an $11B market cap and 5x EBITDA, Owens Corning (NYSE: OC) presents a compelling asymmetric investment thesis as a forecasted >90% probability 2026/2027 "Super El Niño" prepares to drive massive, non-discretionary, insurance-funded roofing repair demand across the Southeast United States. Historical parallels from the 2015–2016 and 2023–2024 El Niño cycles demonstrate clear operating leverage, where severe storm activity doubled roofing EBIT and generated 2x to 3x stock returns within 12 to 24 months. Modeling a 35% (base) to ~50% (bull) EBITDA expansion at a standard 9x EV/EBITDA multiple points to a 2x base-case to nearly 3x bull-case upside over the next 12 months, supported by a ~2.5% dividend yield and tactical plant expansions in Ohio and Alabama. Primary risks include asphalt input price spikes linked to high crude oil prices and ongoing integration or tariff friction from the $3.9B Masonite acquisition. However, the thesis features a deep margin of safety anchored by a elevated trough EBITDA margin floor of 24–34% (up from 13–16% in past cycles), cost-saving vertical integration via in-house asphalt oxidation, and strict insurance policy timelines that compel homeowners to replace damaged roofs regardless of broader macroeconomic weakness.
@StableBread

Fajasy on X

BWX Technologies $BWXT is in military base power three ways, through (1) Project Pele, a prototype reactor it’s building for the Pentagon, (2) the TRISO fuel its microreactors run on, and (3) Janus, the Army program that chose $BWXT’s commercial reactor for Fort Campbell, Kentucky. Pele is a 1.5-megawatt (MW) transportable, gas-cooled microreactor built for the Pentagon’s Strategic Capabilities Office under a 2022 award. $BWXT delivered its full TRISO fuel core to Idaho National Laboratory (INL) in December 2025, received the Department of Energy’s (DOE) preliminary safety approval in September 2026, and targets delivering the reactor to INL in 2027. TRISO (tri-structural isotropic) fuel, which the Department of Energy calls “the most robust nuclear fuel on earth,” packs uranium into particles coated in carbon and ceramic layers. $BWXT produces TRISO at Lynchburg “in the hundreds of kilograms quantities,” Joe Miller, president of Government Operations, said at its Investor Day on September 29, 2026. It also supplied the fuel for Antares, a microreactor startup whose reactor was the first new reactor to reach criticality (a self-sustaining chain reaction) under DOE’s reactor pilot program in June 2026. POWER magazine, a power-industry trade publication, reports $BWXT is “the only Janus vendor that self-supplies its TRISO fuel.” $BWXT is also negotiating a commercial TRISO plant in Wyoming with Kairos Power, an advanced reactor developer, at up to $500M of capex. CFO Mike Fitzgerald said at Investor Day that $BWXT needs to see high-assay low-enriched uranium (HALEU, the 5-20% enriched uranium most advanced reactors need) become available before committing to the plant, and “probably will not make a decision on that for a little while.” The Army chose BANR (the BWXT Advanced Nuclear Reactor), a 20 MWe (megawatts of electricity) gas-cooled design scaled up from Pele, for Fort Campbell. $BWXT plans to start construction at the site in late 2028 and have the reactor running in the early 2030s. Three details matter here: 1) No contract value: $BWXT’s release describes “a phased contracting approach.” For comparison, the Janus agreement for Radiant, a microreactor startup, is worth up to $750M. 2) $BWXT will own the reactor: The Army chose vendors “to own, construct and operate nuclear microreactors” ($BWXT’s release), under fixed-price, milestone-based agreements in which the Army pays at milestones rather than buying power. 3) Not first in line: With operation in the early 2030s, $BWXT’s reactor won’t meet the September 30, 2028 deadline a May 2025 executive order set for an Army-regulated reactor running on a U.S. military base. Radiant and Antares, two of the other Janus vendors, both target 2028 for their first reactors. After Radiant’s agreement, $1.45B of the program’s $2.2B is left, and an even split among the other four vendors would give $BWXT ~$360M over fiscal 2027-2031, or $72M/year, under 2% of 2026 revenue guidance.

Investor Letters

All letters

TSOH Weekly Roundup (10/09/2026)

Paramount Skydance’s debt-heavy Warner Bros. Discovery acquisition, streaming bundle pricing and alcohol-industry diversification anchor…

WBD $78B
TSOH Investment Research

Boyz in the Hood

Robinhood’s AI agents, 24/7 equity trading and 10:1 crypto perpetual futures encourage higher retail trading velocity, leverage and…

HOOD $98B
WHAT ARE WE DOING? “Contrarians At The Gate”

Namib Minerals: Research Note

Namib Minerals posted H1 adjusted EBITDA of $19.0 million, up 76%, as higher gold prices offset lower production.

NAMM $62M
Atrium Research - Equity Research
BNTC · long

Benitec Biopharma INC

Benitec Biopharma's BB-301 gene therapy is in a Phase 1b/2a trial for an ultra-rare muscular dystrophy.

BNTC $314M
Value Investors Club

Golar LNG q2’26 Operational Update

Golar LNG ordered a $2.45 billion fourth FLNG vessel, targeting 3.5MTPA of capacity and $400 million in annual EBITDA under a 20-year…

GLNG $4.9B
Monte Independent Investment Research

Top Rebound Stocks for Oct’26

Intuitive Surgical, down 32% from its January 2025 peak, faces slower US procedure growth and new robotic-surgery rivals despite $10.1…

ISRG $147B
Rebound Capital 1 click

Publications we follow

Every publication on this site, hand-picked.

109 publications

Newsletters 92

YouTube 4

Blogs 12

Seeking Alpha 45 of 216

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

74 accounts
Nominate an account

Investor letters we follow

189 firms

Sectors

Ordered by how often our editor reaches for them.